Ubs Asset Management Americas Inc Catalent, Inc. Transaction History

Ubs Asset Management Americas Inc

$381 Billion
Q3 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Catalent, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 1,024,240 shares of CTLT stock, worth $62.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,024,240

Previous 978,676 4.66%

Holding current value

$62.2 Million

Previous $55 Million 12.73%

% of portfolio

0.02%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$56.16 - $60.96 $2.56 Million - $2.78 Million	45,564 Added 4.66%	1,024,240 $62 Million
Q2 2024 Aug 13, 2024	BUY	$53.58 - $57.02 $22.5 Million - $23.9 Million	419,541 Added 75.03%	978,676 $55 Million
Q1 2024 May 15, 2024	SELL	$42.56 - $59.82 $488,290 - $686,314	-11,473 Reduced 2.01%	559,135 $31.6 Million
Q4 2023 Feb 14, 2024	SELL	$32.18 - $46.57 $355,589 - $514,598	-11,050 Reduced 1.9%	570,608 $25.6 Million
Q3 2023 Nov 13, 2023	BUY	$44.2 - $50.2 $192,800 - $218,972	4,362 Added 0.76%	581,658 $26.5 Million
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $818,010 - $1.34 Million	18,002 Added 3.22%	577,296 $37.9 Million
Q4 2022 Feb 14, 2023	SELL	$41.39 - $81.0 $551,728 - $1.08 Million	-13,330 Reduced 2.33%	559,294 $25.2 Million
Q3 2022 Nov 14, 2022	SELL	$72.36 - $113.1 $36,469 - $57,002	-504 Reduced 0.09%	572,624 $41.4 Million
Q2 2022 Aug 12, 2022	BUY	$87.2 - $114.05 $2.39 Million - $3.12 Million	27,397 Added 5.02%	573,128 $61.5 Million
Q1 2022 May 16, 2022	SELL	$94.19 - $124.49 $1.18 Million - $1.56 Million	-12,568 Reduced 2.25%	545,731 $60.5 Million
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $351,177 - $408,448	2,937 Added 0.53%	558,299 $71.5 Million
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $419,758 - $547,335	3,845 Added 0.7%	555,362 $73.9 Million
Q2 2021 Aug 16, 2021	BUY	$100.34 - $115.69 $2.38 Million - $2.74 Million	23,695 Added 4.49%	551,517 $59.6 Million
Q1 2021 May 14, 2021	BUY	$101.51 - $125.27 $2.42 Million - $2.99 Million	23,845 Added 4.73%	527,822 $55.6 Million
Q4 2020 Mar 01, 2021	BUY	$85.88 - $105.36 $2.76 Million - $3.38 Million	32,098 Added 6.8%	503,977 $52.4 Million
Q3 2020 Nov 13, 2020	BUY	$72.74 - $92.5 $6.07 Million - $7.72 Million	83,508 Added 21.5%	471,879 $40.4 Million
Q2 2020 Aug 14, 2020	BUY	$48.02 - $79.04 $9.16 Million - $15.1 Million	190,816 Added 96.59%	388,371 $28.5 Million
Q1 2020 May 15, 2020	BUY	$36.95 - $62.95 $1.02 Million - $1.73 Million	27,550 Added 16.21%	197,555 $10.3 Million
Q4 2019 Feb 14, 2020	SELL	$47.06 - $56.64 $1.66 Million - $2 Million	-35,310 Reduced 17.2%	170,005 $9.57 Million
Q3 2019 Nov 14, 2019	BUY	$47.45 - $58.05 $378,271 - $462,774	7,972 Added 4.04%	205,315 $9.79 Million
Q2 2019 Aug 15, 2019	BUY	$39.26 - $54.21 $221,504 - $305,852	5,642 Added 2.94%	197,343 $0
Q1 2019 May 14, 2019	BUY	$29.84 - $43.92 $787,507 - $1.16 Million	26,391 Added 15.96%	191,701 $0
Q4 2018 Feb 13, 2019	BUY	$29.95 - $46.34 $157,716 - $244,026	5,266 Added 3.29%	165,310 $5.15 Million
Q3 2018 Nov 14, 2018	BUY	$40.12 - $45.55 $551,329 - $625,948	13,742 Added 9.39%	160,044 $0
Q2 2018 Aug 14, 2018	SELL	$38.72 - $42.52 $2.04 Million - $2.24 Million	-52,599 Reduced 26.44%	146,302 $0
Q1 2018 May 14, 2018	SELL	$39.4 - $47.39 $3.38 Million - $4.06 Million	-85,772 Reduced 30.13%	198,901 $0
Q4 2017 Feb 09, 2018	BUY	$37.27 - $43.02 $1.28 Million - $1.48 Million	34,300 Added 13.7%	284,673 $0
Q3 2017 Nov 13, 2017	BUY	$33.75 - $41.67 $8.45 Million - $10.4 Million	250,373	250,373 $0

Others Institutions Holding CTLT

# of Institutions

514

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Catalent, Inc. Transaction History